ES413639A1 - Dopamine derivatives - Google Patents
Dopamine derivativesInfo
- Publication number
- ES413639A1 ES413639A1 ES413639A ES413639A ES413639A1 ES 413639 A1 ES413639 A1 ES 413639A1 ES 413639 A ES413639 A ES 413639A ES 413639 A ES413639 A ES 413639A ES 413639 A1 ES413639 A1 ES 413639A1
- Authority
- ES
- Spain
- Prior art keywords
- hydrogen
- radicals
- methyl
- methoxy
- hydroxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
- C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
- C07C45/46—Friedel-Crafts reactions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hospice & Palliative Care (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
A procedure for the preparation of a dopamine derived compound of formula I **(See formula)** where R and R1 are hydrogen or methyl, at least one of the radicals R or R1 being hydrogen; R2 and R3 are hydrogen or hydroxy, at least one of the radicals R2 or R3 being hydroxy; n is 1 or 2 and, when n is 1 and R2 and R3 are both hydroxy, then R or R1 is methyl; and the pharmaceutically acceptable mineral acid addition salts thereof, the process of which is characterized by reacting with hydrobromic acid a compound of formula II **(See formula)** where R and R1 are hydrogen or methyl, at least one of the radicals R or R1 being hydrogen; R2 and R3 are hydrogen or methoxy, at least one of the radicals R2 or R3 being methoxy; n is 1 or 2; and, when n is 1 and R2 and R3 are both methoxy, then R or R1 is methyl and optionally convert it to its pharmaceutically acceptable salts. (Machine-translation by Google Translate, not legally binding)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US24346672A | 1972-04-12 | 1972-04-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES413639A1 true ES413639A1 (en) | 1976-01-16 |
Family
ID=22918877
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES413639A Expired ES413639A1 (en) | 1972-04-12 | 1973-04-12 | Dopamine derivatives |
Country Status (31)
| Country | Link |
|---|---|
| JP (2) | JPS5825656B2 (en) |
| KR (1) | KR790000113B1 (en) |
| AR (1) | AR203822A1 (en) |
| AT (1) | AT323719B (en) |
| AU (1) | AU472734B2 (en) |
| BE (1) | BE798051A (en) |
| BG (1) | BG23001A3 (en) |
| CA (1) | CA1018188A (en) |
| CH (2) | CH580563A5 (en) |
| CS (2) | CS190448B2 (en) |
| CY (1) | CY963A (en) |
| DD (1) | DD107670B3 (en) |
| DE (1) | DE2317710C2 (en) |
| DK (1) | DK142750C (en) |
| ES (1) | ES413639A1 (en) |
| FR (1) | FR2182947B1 (en) |
| GB (1) | GB1392674A (en) |
| HK (1) | HK50178A (en) |
| HU (2) | HU167597B (en) |
| IE (1) | IE37511B1 (en) |
| IL (1) | IL42016A (en) |
| KE (1) | KE2870A (en) |
| MY (1) | MY7800381A (en) |
| NL (1) | NL174459C (en) |
| PH (1) | PH11041A (en) |
| PL (2) | PL94207B1 (en) |
| RO (2) | RO70892A (en) |
| SE (1) | SE399064B (en) |
| SU (1) | SU496719A3 (en) |
| YU (2) | YU36483B (en) |
| ZA (1) | ZA732136B (en) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH585693A5 (en) * | 1974-02-08 | 1977-03-15 | Ciba Geigy Ag | |
| US4342692A (en) * | 1980-10-20 | 1982-08-03 | Usv Pharmaceutical Corporation | Pyrrolidines |
| NO822514L (en) * | 1981-07-22 | 1983-01-24 | Syntex Inc | PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVITY 2,5-SUBSTITUTED PYRROLIDE INGREDIENTS |
| JPS6061523A (en) * | 1983-09-16 | 1985-04-09 | Shionogi & Co Ltd | Oral dobutamine pharmaceutical |
| IL85438A0 (en) * | 1987-02-24 | 1988-07-31 | Lilly Co Eli | Improvements in or relating to dobutamine salts |
| JPH0383364U (en) * | 1989-12-18 | 1991-08-23 | ||
| WO1992020645A1 (en) * | 1991-05-20 | 1992-11-26 | Tsumura & Co. | Phellodendrine analogs and allergy type iv suppressor containing the same as active ingredient |
| EP0620208B1 (en) * | 1993-04-13 | 1997-07-09 | Duphar International Research B.V | Production of dobutamine compounds |
| DE69404063T2 (en) * | 1993-04-13 | 1998-01-22 | Duphar Int Res | Manufacture of dobutamine compounds |
| AU2003274605A1 (en) | 2002-10-03 | 2004-04-23 | Novaremed Ltd | Compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection |
| EP1750691B1 (en) | 2004-03-26 | 2016-08-10 | Novaremed Ltd. | Compounds for treatment of aids and other diseases |
| GB0804213D0 (en) | 2008-03-06 | 2008-04-16 | New Era Biotech Ltd | A method of printing or preventing pain |
| AU2010278711A1 (en) | 2009-07-31 | 2012-02-23 | Cognition Therapeutics, Inc. | Inhibitors of cognitive decline |
| US8802734B2 (en) | 2009-09-09 | 2014-08-12 | Novaremed Limited | Method of treating or preventing pain |
| US20170197977A9 (en) * | 2011-08-25 | 2017-07-13 | Cognition Therapeutics, Inc. | Compositions and methods for treating neurodegenerative disease |
| ES2721001T3 (en) | 2014-01-31 | 2019-07-26 | Cognition Therapeutics Inc | Isoindoline derivative, and compositions and methods to treat a neurodegenerative disease |
| KR102614814B1 (en) | 2017-05-15 | 2023-12-20 | 카그니션 테라퓨틱스, 인코퍼레이티드 | Composition for treating neurodegenerative diseases |
| CN114524734B (en) * | 2021-12-27 | 2024-04-26 | 嘉实（湖南）医药科技有限公司 | Preparation method of dobutamine hydrochloride |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2276619A (en) * | 1942-03-17 | N-phentlaliphatic-dihtoroxyphentnl |
-
1973
- 1973-03-28 ZA ZA732136A patent/ZA732136B/en unknown
- 1973-04-09 DE DE2317710A patent/DE2317710C2/en not_active Expired
- 1973-04-09 GB GB1683573A patent/GB1392674A/en not_active Expired
- 1973-04-09 CY CY963A patent/CY963A/en unknown
- 1973-04-10 IE IE563/73A patent/IE37511B1/en unknown
- 1973-04-10 SE SE7305032A patent/SE399064B/en unknown
- 1973-04-10 FR FR7312845A patent/FR2182947B1/fr not_active Expired
- 1973-04-11 DK DK196773A patent/DK142750C/en not_active IP Right Cessation
- 1973-04-11 AU AU54385/73A patent/AU472734B2/en not_active Expired
- 1973-04-11 BE BE1004956A patent/BE798051A/en not_active IP Right Cessation
- 1973-04-11 CH CH1112475A patent/CH580563A5/xx not_active IP Right Cessation
- 1973-04-11 BG BG023268A patent/BG23001A3/en unknown
- 1973-04-11 CH CH517473A patent/CH569691A5/xx not_active IP Right Cessation
- 1973-04-11 SU SU1908277A patent/SU496719A3/en active
- 1973-04-11 YU YU00976/73A patent/YU36483B/en unknown
- 1973-04-11 AT AT318773A patent/AT323719B/en not_active IP Right Cessation
- 1973-04-11 KR KR7300573A patent/KR790000113B1/en active
- 1973-04-11 NL NLAANVRAGE7305097,A patent/NL174459C/en not_active IP Right Cessation
- 1973-04-11 CA CA168,428A patent/CA1018188A/en not_active Expired
- 1973-04-12 ES ES413639A patent/ES413639A1/en not_active Expired
- 1973-04-12 CS CS77171A patent/CS190448B2/en unknown
- 1973-04-12 AR AR247523A patent/AR203822A1/en active
- 1973-04-12 RO RO7383749A patent/RO70892A/en unknown
- 1973-04-12 CS CS732601A patent/CS190406B2/en unknown
- 1973-04-12 RO RO7374457A patent/RO65105A/en unknown
- 1973-04-12 JP JP48041750A patent/JPS5825656B2/en not_active Expired
- 1973-04-12 IL IL42016A patent/IL42016A/en unknown
- 1973-04-12 DD DD73170118A patent/DD107670B3/en unknown
- 1973-04-12 PL PL1973183808A patent/PL94207B1/pl unknown
- 1973-04-12 PL PL1973161874A patent/PL90695B1/pl unknown
- 1973-04-12 HU HUEI552A patent/HU167597B/hu unknown
- 1973-04-12 PH PH14508A patent/PH11041A/en unknown
- 1973-04-12 HU HUEI469A patent/HU166213B/hu unknown
-
1978
- 1978-08-10 KE KE2870A patent/KE2870A/en unknown
- 1978-09-07 HK HK501/78A patent/HK50178A/en unknown
- 1978-12-30 MY MY381/78A patent/MY7800381A/en unknown
-
1979
- 1979-12-28 YU YU3212/79A patent/YU37113B/en unknown
-
1982
- 1982-08-27 JP JP57149025A patent/JPS58131945A/en active Granted
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES413639A1 (en) | Dopamine derivatives | |
| ES456279A1 (en) | 16,17,18,19,20-pentanorprostaglandins | |
| ES387016A1 (en) | Isoquinoline derivatives | |
| ES439909A1 (en) | 2-thiol-4,5-diphenyloxazole s-derivatives | |
| ES447664A1 (en) | Cardenolide derivatives | |
| ES405479A1 (en) | Benzodiazepin-2-ones | |
| ES421182A1 (en) | Propanolamine derivatives | |
| ES419386A1 (en) | Indenopyrrole derivatives | |
| ES378206A1 (en) | 2-(imidazolid inylidence-(2)-amino)-5-nitro-thiazoles and salts thereof | |
| ES418841A1 (en) | Derivatives of pyridine-3-acetic acid | |
| ES412068A1 (en) | Xylidides | |
| ES364980A1 (en) | A method for preparing new adamantan derivatives. (Machine-translation by Google Translate, not legally binding) | |
| ES442612A1 (en) | Isoquinoline compounds | |
| ES461191A1 (en) | New nn**11piperidinyl*alkyl* aryl carboxysamide derivative | |
| ES472572A1 (en) | F3-phenoxy-n-substituted morphinan derivatives their manufacture and pharmaceutical preparations containing them | |
| ES405080A1 (en) | Bis-(para-chlorophenoxy)carbinol and ethers thereof | |
| ES402551A1 (en) | A procedure for the preparation of piperazine derivatives. (Machine-translation by Google Translate, not legally binding) | |
| ES405281A1 (en) | Cephalosporin compounds | |
| ES417269A1 (en) | 3-azetidinylethyl-1-phenyl-2-midazolidinone derivatives | |
| ES410009A1 (en) | Process for preparing 7-acylamino-3-substituted-3-cephem-4- carboxylic acid derivatives | |
| ES366913A1 (en) | A procedure for the preparation of therapeutically active substitute cyclohexanes. (Machine-translation by Google Translate, not legally binding) | |
| ES427622A1 (en) | Procedure for the preparation of 2-amino-bencil-amines. (Machine-translation by Google Translate, not legally binding) | |
| ES334733A1 (en) | Procedure for preparing derivatives of acid esters-5halobenzoicos. (Machine-translation by Google Translate, not legally binding) | |
| ES379617A1 (en) | A process for the manufacture of amino acids and derivatives thereof | |
| ES385679A1 (en) | N-arylidene derivatives of erythromycylamine |